A citation-based method for searching scientific literature

Jingyi Lu, Xiaojing Ma, Jian Zhou, Lei Zhang, Yifei Mo, Lingwen Ying, Wei Lu, Wei Zhu, Yuqian Bao, Robert A Vigersky, Weiping Jia. Diabetes Care 2018
Times Cited: 150







List of co-cited articles
556 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Effect of Continuous Glucose Monitoring on Hypoglycemia in Older Adults With Type 1 Diabetes: A Randomized Clinical Trial.
Richard E Pratley, Lauren G Kanapka, Michael R Rickels, Andrew Ahmann, Grazia Aleppo, Roy Beck, Anuj Bhargava, Bruce W Bode, Anders Carlson, Naomi S Chaytor,[...]. JAMA 2020
34
11


Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).
Melanie J Davies, David A D'Alessio, Judith Fradkin, Walter N Kernan, Chantal Mathieu, Geltrude Mingrone, Peter Rossing, Apostolos Tsapas, Deborah J Wexler, John B Buse. Diabetologia 2018
514
4

Day-to-day fasting glycaemic variability in DEVOTE: associations with severe hypoglycaemia and cardiovascular outcomes (DEVOTE 2).
Bernard Zinman, Steven P Marso, Neil R Poulter, Scott S Emerson, Thomas R Pieber, Richard E Pratley, Martin Lange, Kirstine Brown-Frandsen, Alan Moses, Ann Marie Ocampo Francisco,[...]. Diabetologia 2018
83
4

Lag Time Remains with Newer Real-Time Continuous Glucose Monitoring Technology During Aerobic Exercise in Adults Living with Type 1 Diabetes.
Dessi P Zaharieva, Kamuran Turksoy, Sarah M McGaugh, Rubin Pooni, Todd Vienneau, Trang Ly, Michael C Riddell. Diabetes Technol Ther 2019
36
11



Association of time in range, as assessed by continuous glucose monitoring, with painful diabetic polyneuropathy.
Junpeng Yang, Xueli Yang, Dongni Zhao, Xiaobing Wang, Wei Wei, Huijuan Yuan. J Diabetes Investig 2021
6
66

Robust Determination of the Optimal Continuous Glucose Monitoring Length of Intervention to Evaluate Long-Term Glycemic Control.
Pau Herrero, Antonia Alalitei, Monika Reddy, Pantelis Georgiou, Nick Oliver. Diabetes Technol Ther 2021
10
40

Continuous glucose monitoring for patients with type 1 diabetes and impaired awareness of hypoglycaemia (IN CONTROL): a randomised, open-label, crossover trial.
Cornelis A J van Beers, J Hans DeVries, Susanne J Kleijer, Mark M Smits, Petronella H Geelhoed-Duijvestijn, Mark H H Kramer, Michaela Diamant, Frank J Snoek, Erik H Serné. Lancet Diabetes Endocrinol 2016
161
4


Hypoglycemia and diabetes: a report of a workgroup of the American Diabetes Association and the Endocrine Society.
Elizabeth R Seaquist, John Anderson, Belinda Childs, Philip Cryer, Samuel Dagogo-Jack, Lisa Fish, Simon R Heller, Henry Rodriguez, James Rosenzweig, Robert Vigersky. Diabetes Care 2013
778
3

The "glucose pentagon": assessing glycemic control of patients with diabetes mellitus by a model integrating different parameters from glucose profiles.
Andreas Thomas, Martin Schönauer, Frank Achermann, Oliver Schnell, Markolf Hanefeld, Hans-Jürgen Ziegelasch, John Mastrototaro, Lutz Heinemann. Diabetes Technol Ther 2009
27
11

Statistical tools to analyze continuous glucose monitor data.
William Clarke, Boris Kovatchev. Diabetes Technol Ther 2009
129
3

Assessment of the association between glycemic variability and diabetes-related complications in type 1 and type 2 diabetes.
J Smith-Palmer, M Brändle, R Trevisan, M Orsini Federici, S Liabat, W Valentine. Diabetes Res Clin Pract 2014
101
3

Hemoglobin A1c and mean glucose in patients with type 1 diabetes: analysis of data from the Juvenile Diabetes Research Foundation continuous glucose monitoring randomized trial.
Darrell M Wilson, Dongyuan Xing, Roy W Beck, Jennifer Block, Bruce Bode, Larry A Fox, Irl Hirsch, Craig Kollman, Lori Laffel, Katrina J Ruedy,[...]. Diabetes Care 2011
46
6

Does A1c consistently reflect mean plasma glucose?
David Shrom, Samiha Sarwat, Liza Ilag, Zachary T Bloomgarden. J Diabetes 2010
18
16

Optimizing Hybrid Closed-Loop Therapy in Adolescents and Emerging Adults Using the MiniMed 670G System.
Laurel H Messer, Gregory P Forlenza, Jennifer L Sherr, R Paul Wadwa, Bruce A Buckingham, Stuart A Weinzimer, David M Maahs, Robert H Slover. Diabetes Care 2018
57
5

Postprandial glucose regulation and diabetic complications.
Antonio Ceriello, Markolf Hanefeld, Lawrence Leiter, Louis Monnier, Alan Moses, David Owens, Naoko Tajima, Jaakko Tuomilehto. Arch Intern Med 2004
247
3

Hybrid Closed-Loop Control Is Safe and Effective for People with Type 1 Diabetes Who Are at Moderate to High Risk for Hypoglycemia.
Stacey M Anderson, Bruce A Buckingham, Marc D Breton, Jessica L Robic, Charlotte L Barnett, Christian A Wakeman, Mary C Oliveri, Sue A Brown, Trang T Ly, Paula K Clinton,[...]. Diabetes Technol Ther 2019
18
16

Risk factors for myocardial infarction and death in newly detected NIDDM: the Diabetes Intervention Study, 11-year follow-up.
M Hanefeld, S Fischer, U Julius, J Schulze, U Schwanebeck, H Schmechel, H J Ziegelasch, J Lindner. Diabetologia 1996
702
3

Glycemic variability in continuous glucose monitoring is inversely associated with baroreflex sensitivity in type 2 diabetes: a preliminary report.
Daisuke Matsutani, Masaya Sakamoto, Hiroyuki Iuchi, Souichirou Minato, Hirofumi Suzuki, Yosuke Kayama, Norihiko Takeda, Ryuzo Horiuchi, Kazunori Utsunomiya. Cardiovasc Diabetol 2018
23
13

Improved Postprandial Glucose with Inhaled Technosphere Insulin Compared with Insulin Aspart in Patients with Type 1 Diabetes on Multiple Daily Injections: The STAT Study.
Halis Kaan Akturk, Janet K Snell-Bergeon, Amanda Rewers, Leslie J Klaff, Bruce W Bode, Anne L Peters, Timothy S Bailey, Satish K Garg. Diabetes Technol Ther 2018
19
15

A Prospective Multicenter Evaluation of the Accuracy of a Novel Implanted Continuous Glucose Sensor: PRECISE II.
Mark P Christiansen, Leslie J Klaff, Ronald Brazg, Anna R Chang, Carol J Levy, David Lam, Douglas S Denham, George Atiee, Bruce W Bode, Steven J Walters,[...]. Diabetes Technol Ther 2018
56
5


Accuracy and Longevity of an Implantable Continuous Glucose Sensor in the PRECISE Study: A 180-Day, Prospective, Multicenter, Pivotal Trial.
Jort Kropff, Pratik Choudhary, Sankalpa Neupane, Katharine Barnard, Steve C Bain, Christoph Kapitza, Thomas Forst, Manuela Link, Andrew Dehennis, J Hans DeVries. Diabetes Care 2017
73
4

Association of Glycemic Variability in Type 1 Diabetes With Progression of Microvascular Outcomes in the Diabetes Control and Complications Trial.
John M Lachin, Ionut Bebu, Richard M Bergenstal, Rodica Pop-Busui, F John Service, Bernard Zinman, David M Nathan. Diabetes Care 2017
81
3


Accuracy of flash glucose monitoring and continuous glucose monitoring technologies: Implications for clinical practice.
Ramzi A Ajjan, Michael H Cummings, Peter Jennings, Lalantha Leelarathna, Gerry Rayman, Emma G Wilmot. Diab Vasc Dis Res 2018
31
9

Safety of a Hybrid Closed-Loop Insulin Delivery System in Patients With Type 1 Diabetes.
Richard M Bergenstal, Satish Garg, Stuart A Weinzimer, Bruce A Buckingham, Bruce W Bode, William V Tamborlane, Francine R Kaufman. JAMA 2016
300
3

Postprandial blood glucose predicts cardiovascular events and all-cause mortality in type 2 diabetes in a 14-year follow-up: lessons from the San Luigi Gonzaga Diabetes Study.
Franco Cavalot, Andrea Pagliarino, Manuela Valle, Leonardo Di Martino, Katia Bonomo, Paola Massucco, Giovanni Anfossi, Mariella Trovati. Diabetes Care 2011
189
3

6
50


Effects of Dapagliflozin on 24-Hour Glycemic Control in Patients with Type 2 Diabetes: A Randomized Controlled Trial.
Robert R Henry, Poul Strange, Rong Zhou, Jeremy Pettus, Leon Shi, Sergey B Zhuplatov, Traci Mansfield, David Klein, Arie Katz. Diabetes Technol Ther 2018
27
11



The importance of HbA1c and glucose variability in patients with type 1 and type 2 diabetes: outcome of continuous glucose monitoring (CGM).
Giovanni Sartore, Nino Cristiano Chilelli, Silvia Burlina, Paola Di Stefano, Francesco Piarulli, Domenico Fedele, Andrea Mosca, Annunziata Lapolla. Acta Diabetol 2012
47
6

Sotagliflozin in Combination With Optimized Insulin Therapy in Adults With Type 1 Diabetes: The North American inTandem1 Study.
John B Buse, Satish K Garg, Julio Rosenstock, Timothy S Bailey, Phillip Banks, Bruce W Bode, Thomas Danne, Jake A Kushner, Wendy S Lane, Pablo Lapuerta,[...]. Diabetes Care 2018
101
3

Effect of metformin on glycaemic control in patients with type 1 diabetes: A meta-analysis of randomized controlled trials.
Haiyang Meng, Ailing Zhang, Yan Liang, Jie Hao, Xiaojian Zhang, Jingli Lu. Diabetes Metab Res Rev 2018
23
13

Efficacy and Safety of Dapagliflozin in Patients With Inadequately Controlled Type 1 Diabetes: The DEPICT-1 52-Week Study.
Paresh Dandona, Chantal Mathieu, Moshe Phillip, Lars Hansen, Diethelm Tschöpe, Fredrik Thorén, John Xu, Anna Maria Langkilde. Diabetes Care 2018
95
3

Efficacy and Safety of Dapagliflozin in Patients With Inadequately Controlled Type 1 Diabetes (the DEPICT-2 Study): 24-Week Results From a Randomized Controlled Trial.
Chantal Mathieu, Paresh Dandona, Pieter Gillard, Peter Senior, Christoph Hasslacher, Eiichi Araki, Marcus Lind, Stephen C Bain, Serge Jabbour, Niki Arya,[...]. Diabetes Care 2018
119
3

Efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes (DEPICT-1): 24 week results from a multicentre, double-blind, phase 3, randomised controlled trial.
Paresh Dandona, Chantal Mathieu, Moshe Phillip, Lars Hansen, Steven C Griffen, Diethelm Tschöpe, Fredrik Thorén, John Xu, Anna Maria Langkilde. Lancet Diabetes Endocrinol 2017
156
3

Diabetes Technology-Continuous Subcutaneous Insulin Infusion Therapy and Continuous Glucose Monitoring in Adults: An Endocrine Society Clinical Practice Guideline.
Anne L Peters, Andrew J Ahmann, Tadej Battelino, Alison Evert, Irl B Hirsch, M Hassan Murad, William E Winter, Howard Wolpert. J Clin Endocrinol Metab 2016
100
3

Effects of Sotagliflozin Added to Insulin in Patients with Type 1 Diabetes.
Satish K Garg, Robert R Henry, Phillip Banks, John B Buse, Melanie J Davies, Gregory R Fulcher, Paolo Pozzilli, Diane Gesty-Palmer, Pablo Lapuerta, Rafael Simó,[...]. N Engl J Med 2017
198
3

International Consensus on Risk Management of Diabetic Ketoacidosis in Patients With Type 1 Diabetes Treated With Sodium-Glucose Cotransporter (SGLT) Inhibitors.
Thomas Danne, Satish Garg, Anne L Peters, John B Buse, Chantal Mathieu, Jeremy H Pettus, Charles M Alexander, Tadej Battelino, F Javier Ampudia-Blasco, Bruce W Bode,[...]. Diabetes Care 2019
106
3

Metabolic response to sodium-glucose cotransporter 2 inhibition in type 2 diabetic patients.
Ele Ferrannini, Elza Muscelli, Silvia Frascerra, Simona Baldi, Andrea Mari, Tim Heise, Uli C Broedl, Hans-Juergen Woerle. J Clin Invest 2014
622
3

Dapagliflozin improves muscle insulin sensitivity but enhances endogenous glucose production.
Aurora Merovci, Carolina Solis-Herrera, Giuseppe Daniele, Roy Eldor, Teresa Vanessa Fiorentino, Devjit Tripathy, Juan Xiong, Zandra Perez, Luke Norton, Muhammad A Abdul-Ghani,[...]. J Clin Invest 2014
471
3

Parsimonious Description of Glucose Variability in Type 2 Diabetes by Sparse Principal Component Analysis.
Chiara Fabris, Andrea Facchinetti, Giuseppe Fico, Francesco Sambo, Maria Teresa Arredondo, Claudio Cobelli. J Diabetes Sci Technol 2015
23
13

Glucose variability indices in type 1 diabetes: parsimonious set of indices revealed by sparse principal component analysis.
Chiara Fabris, Andrea Facchinetti, Giovanni Sparacino, Mattia Zanon, Stefania Guerra, Alberto Maran, Claudio Cobelli. Diabetes Technol Ther 2014
34
8

Defining High Glycemic Variability in Type 1 Diabetes: Comparison of Multiple Indexes to Identify Patients at Risk of Hypoglycemia.
Ana María Gómez, Diana Cristina Henao, Angélica Imitola Madero, Lucía B Taboada, Viviana Cruz, María Alejandra Robledo Gómez, Martin Rondón, Oscar Muñoz-Velandia, Maira García-Jaramillo, Fabian Mauricio León Vargas. Diabetes Technol Ther 2019
18
16


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.